Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases

Mario Mandalà, Monica F Chen, Ryan J Sullivan, Maria Chiara Sergi, Michael Postow, Aleigha R Lawless, Derek Effiom, Tobias Peres, Paul C Lorigan, Patricio Serra-Bellver, Reinhard Dummer, Teresa Amaral, Marie-Lena Rasch, Diana Giannarelli, Maria Grazia Vitale, Hildur Helgadottir, Caroline Robert, Martina Ubaldi, Douglas B Johnson, Michele Del Vecchio, Alice Indini, Karijn P M Suijkerbuijk, Paul Nathan, Thomas Carter, Bart Neyns, Iris Dirven, Ines Pires da Silva, Alexander Maxwell Menzies, Lisa Zimmer, Elisabeth Livingstone, Roberta Depenni, Katharina Kähler, Axel Hauschild, Francesco Spagnolo, Anna Maria Di Giacomo, Ana Arance, Barbara Merelli, Pietro Quaglino, Ernesto Rossi, Marco Tucci, Michele Guida, Eva Muñoz-Couselo, Georgina V Long, James Larkin, Paolo A Ascierto

Open source

DOI: 10.1136/jitc-2026-015063
Published: 2026-05
Container: Journal for ImmunoTherapy of Cancer
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2026-015063,
  title = {Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases},
  author = {Mario Mandalà and Monica F Chen and Ryan J Sullivan and Maria Chiara Sergi and Michael Postow and Aleigha R Lawless and Derek Effiom and Tobias Peres and Paul C Lorigan and Patricio Serra-Bellver and Reinhard Dummer and Teresa Amaral and Marie-Lena Rasch and Diana Giannarelli and Maria Grazia Vitale and Hildur Helgadottir and Caroline Robert and Martina Ubaldi and Douglas B Johnson and Michele Del Vecchio and Alice Indini and Karijn P M Suijkerbuijk and Paul Nathan and Thomas Carter and Bart Neyns and Iris Dirven and Ines Pires da Silva and Alexander Maxwell Menzies and Lisa Zimmer and Elisabeth Livingstone and Roberta Depenni and Katharina Kähler and Axel Hauschild and Francesco Spagnolo and Anna Maria Di Giacomo and Ana Arance and Barbara Merelli and Pietro Quaglino and Ernesto Rossi and Marco Tucci and Michele Guida and Eva Muñoz-Couselo and Georgina V Long and James Larkin and Paolo A Ascierto},
  year = {2026},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2026-015063},
  url = {https://doi.org/10.1136/jitc-2026-015063}
}

RIS

TY  - JOUR
TI  - Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases
AU  - Mario Mandalà
AU  - Monica F Chen
AU  - Ryan J Sullivan
AU  - Maria Chiara Sergi
AU  - Michael Postow
AU  - Aleigha R Lawless
AU  - Derek Effiom
AU  - Tobias Peres
AU  - Paul C Lorigan
AU  - Patricio Serra-Bellver
AU  - Reinhard Dummer
AU  - Teresa Amaral
AU  - Marie-Lena Rasch
AU  - Diana Giannarelli
AU  - Maria Grazia Vitale
AU  - Hildur Helgadottir
AU  - Caroline Robert
AU  - Martina Ubaldi
AU  - Douglas B Johnson
AU  - Michele Del Vecchio
AU  - Alice Indini
AU  - Karijn P M Suijkerbuijk
AU  - Paul Nathan
AU  - Thomas Carter
AU  - Bart Neyns
AU  - Iris Dirven
AU  - Ines Pires da Silva
AU  - Alexander Maxwell Menzies
AU  - Lisa Zimmer
AU  - Elisabeth Livingstone
AU  - Roberta Depenni
AU  - Katharina Kähler
AU  - Axel Hauschild
AU  - Francesco Spagnolo
AU  - Anna Maria Di Giacomo
AU  - Ana Arance
AU  - Barbara Merelli
AU  - Pietro Quaglino
AU  - Ernesto Rossi
AU  - Marco Tucci
AU  - Michele Guida
AU  - Eva Muñoz-Couselo
AU  - Georgina V Long
AU  - James Larkin
AU  - Paolo A Ascierto
PY  - 2026
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-015063
UR  - https://doi.org/10.1136/jitc-2026-015063
ER  -

APA

Mandalà, M., Chen, M. F., Sullivan, R. J., Sergi, M. C., Postow, M., Lawless, A. R., Effiom, D., Peres, T., Lorigan, P. C., Serra-Bellver, P., Dummer, R., Amaral, T., Rasch, M., Giannarelli, D., Vitale, M. G., Helgadottir, H., Robert, C., Ubaldi, M., Johnson, D. B., Vecchio, M. D., Indini, A., Suijkerbuijk, K. P. M., Nathan, P., Carter, T., Neyns, B., Dirven, I., Silva, I. P. D., Menzies, A. M., Zimmer, L., Livingstone, E., Depenni, R., Kähler, K., Hauschild, A., Spagnolo, F., Giacomo, A. M. D., Arance, A., Merelli, B., Quaglino, P., Rossi, E., Tucci, M., Guida, M., Muñoz-Couselo, E., Long, G. V., Larkin, J., & Ascierto, P. A. (2026). Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2026-015063

Source records

crossref · retrieved 2026-09-25T08:38:25.218Z